1. Home
  2. HHH vs LGND Comparison

HHH vs LGND Comparison

Compare HHH & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Howard Hughes Holdings Inc.

HHH

Howard Hughes Holdings Inc.

HOLD

Current Price

$62.69

Market Cap

3.9B

Sector

Real Estate

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$232.16

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HHH
LGND
Founded
2010
1987
Country
United States
United States
Employees
N/A
68
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.7B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
HHH
LGND
Price
$62.69
$232.16
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$90.00
$256.29
AVG Volume (30 Days)
377.4K
181.1K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.21
N/A
Revenue
$1,474,892,000.00
N/A
Revenue This Year
$14.04
$1.25
Revenue Next Year
N/A
$19.41
P/E Ratio
$28.10
$76.27
Revenue Growth
N/A
N/A
52 Week Low
$61.01
$98.90
52 Week High
$91.07
$247.38

Technical Indicators

Market Signals
Indicator
HHH
LGND
Relative Strength Index (RSI) 38.94 57.83
Support Level $61.84 $180.85
Resistance Level $65.56 N/A
Average True Range (ATR) 1.45 10.07
MACD -0.08 -0.17
Stochastic Oscillator 16.81 40.66

Price Performance

Historical Comparison
HHH
LGND

About HHH Howard Hughes Holdings Inc.

Howard Hughes Holdings Inc, through its subsidiary, operates a large-scale, mixed-use real estate platform focused on the development of master planned communities (MPCs), the investment in strategic real estate development opportunities, and the ownership and operation of income-producing properties. The group operates through three reportable business segments: Operating Assets, MPCs, and Strategic Developments. Maximum revenue is generated from the MPC segment, which consists of the development and sale of land in large-scale, long-term community development projects in and around Las Vegas, Nevada; Houston, Texas; and Phoenix, Arizona. Revenues are mainly generated through the sale of residential and commercial land to homebuilders and developers.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: